[CITATION][C] Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. Sci Transl Med 7 (315): 315ra188

P Muller, M Kreuzaler, T Khan, DS Thommen, K Martin… - 2015
Save Cite Cited by 2 Related articles